Literature DB >> 15728573

Testing the role of gp96 as peptide chaperone in antigen processing.

Rodion Demine1, Peter Walden.   

Abstract

gp96 is a 96-kDa glycoprotein of the endoplasmic reticulum that is believed to be involved in antigen processing as an intermediate carrier of peptides for presentation by major histocompatibility complex (MHC) class I molecules. This function implies that gp96 carries a large array of different peptides that represent the antigenicity of the cell and can serve all MHC class I molecules. So far, the evidence regarding these peptides is largely indirect and based on experiments where mice immunized with gp96 from tumor or virus-infected cells developed T cellular immune responses with the corresponding specificities. We analyzed by mass spectrometry peptides isolated from gp96 and found a number of different peptides derived from the proteins of different cellular compartments but mostly cytoplasm and nucleus. The sequences of these peptides provide information on the specificity of antigen processing and reveal structural requirements for binding to gp96 that only partially correspond to those of peptides presented by MHC class I molecules. The yield of peptides extracted from gp96 was far substoichiometric with an estimated occupancy of this chaperone of between 0.1% and 0.4%. These results strongly argue against a regular role for gp96 as a peptide chaperone in antigen processing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728573     DOI: 10.1074/jbc.M501233200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation.

Authors:  Avital Lev; Kazuyo Takeda; Damien Zanker; Jason C Maynard; Peniel Dimberu; Elizabeth Waffarn; James Gibbs; Nir Netzer; Michael F Princiotta; Len Neckers; Didier Picard; Christopher V Nicchitta; Weisan Chen; Yoram Reiter; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

2.  Re-examination of CD91 function in GRP94 (glycoprotein 96) surface binding, uptake, and peptide cross-presentation.

Authors:  Angela R Jockheck-Clark; Edith V Bowers; Mariam B Totonchy; Julie Neubauer; Salvatore V Pizzo; Christopher V Nicchitta
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

Review 3.  Caught with their PAMPs down? The extracellular signalling actions of molecular chaperones are not due to microbial contaminants.

Authors:  Brian Henderson; Stuart K Calderwood; Anthony R M Coates; Irun Cohen; Willem van Eden; Thomas Lehner; A Graham Pockley
Journal:  Cell Stress Chaperones       Date:  2010-03       Impact factor: 3.667

4.  Immunosurveillance of cancer and the heat shock protein-CD91 pathway.

Authors:  Robert J Binder
Journal:  Cell Immunol       Date:  2018-05-16       Impact factor: 4.868

Review 5.  Functions of heat shock proteins in pathways of the innate and adaptive immune system.

Authors:  Robert Julian Binder
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

6.  Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation.

Authors:  Margaret K Callahan; Manish Garg; Pramod K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

7.  Efficient cross-priming of antiviral CD8+ T cells by antigen donor cells is GRP94 independent.

Authors:  Avital Lev; Peniel Dimberu; Suman R Das; Jason C Maynard; Christopher V Nicchitta; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

8.  Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination.

Authors:  Taylor H Schreiber; Vadim V Deyev; Joseph D Rosenblatt; Eckhard R Podack
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

9.  High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells.

Authors:  Saulius Jarmalavicius; Yvonne Welte; Peter Walden
Journal:  J Biol Chem       Date:  2012-08-06       Impact factor: 5.157

Review 10.  Relationship between head and neck cancer therapy and some genetic endpoints.

Authors:  Eliana Maria Minicucci; Glenda Nicioli da Silva; Daisy Maria Fávero Salvadori
Journal:  World J Clin Oncol       Date:  2014-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.